TAIDOC TECHNOLOGY CORP (4736) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.024x

Based on the latest financial reports, TAIDOC TECHNOLOGY CORP (4736) has a cash flow conversion efficiency ratio of 0.024x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$238.93 Million ≈ $7.53 Million USD) by net assets (NT$9.96 Billion ≈ $313.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See TAIDOC TECHNOLOGY CORP (4736) defensive interval to measure how many days the company can operate on defensive assets alone.

TAIDOC TECHNOLOGY CORP - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how TAIDOC TECHNOLOGY CORP's cash flow conversion efficiency has evolved over time, based on yearly financial data.

TAIDOC TECHNOLOGY CORP Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of TAIDOC TECHNOLOGY CORP ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Chongqing YuXin Pingrui Electronic Co. Ltd.
SHE:301107
0.011x
Raisio Oyj Vaihto-osake
HE:RAIVV
0.035x
Shaanxi Jinye Science Technology and Education Group Co Ltd
SHE:000812
0.148x
Ample Electronic Technology Co Ltd
TWO:4760
-0.014x
Zhongxing Shenyang Commercial Building Group Co Ltd
SHE:000715
0.029x
Sprout Social Inc
NASDAQ:SPT
0.117x
Orthofix Medical Inc
NASDAQ:OFIX
-0.040x
Enseval Putra Megatrading Tbk
JK:EPMT
0.035x

Annual Cash Flow Conversion Efficiency for TAIDOC TECHNOLOGY CORP (2009–2025)

The table below shows the annual cash flow conversion efficiency of TAIDOC TECHNOLOGY CORP from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of TAIDOC TECHNOLOGY CORP.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-09-30 NT$10.12 Billion
≈ $318.98 Million
NT$853.39 Million
≈ $26.89 Million
0.084x +542.57%
2024-09-30 NT$9.52 Billion
≈ $300.01 Million
NT$-181.37 Million
≈ $-5.71 Million
-0.019x -115.05%
2023-09-30 NT$9.26 Billion
≈ $291.71 Million
NT$1.17 Billion
≈ $36.93 Million
0.127x -60.58%
2022-09-30 NT$9.99 Billion
≈ $314.89 Million
NT$3.21 Billion
≈ $101.12 Million
0.321x +27.70%
2021-09-30 NT$7.63 Billion
≈ $240.53 Million
NT$1.92 Billion
≈ $60.48 Million
0.251x -1.04%
2020-09-30 NT$6.62 Billion
≈ $208.59 Million
NT$1.68 Billion
≈ $53.00 Million
0.254x +5.41%
2019-09-30 NT$4.51 Billion
≈ $142.12 Million
NT$1.09 Billion
≈ $34.26 Million
0.241x +23.91%
2018-09-30 NT$4.02 Billion
≈ $126.75 Million
NT$782.66 Million
≈ $24.66 Million
0.195x +18.66%
2017-09-30 NT$3.18 Billion
≈ $100.15 Million
NT$521.21 Million
≈ $16.42 Million
0.164x -20.71%
2016-09-30 NT$3.08 Billion
≈ $96.90 Million
NT$636.01 Million
≈ $20.04 Million
0.207x +18.63%
2015-09-30 NT$2.91 Billion
≈ $91.80 Million
NT$507.88 Million
≈ $16.00 Million
0.174x -26.06%
2014-09-30 NT$2.49 Billion
≈ $78.42 Million
NT$586.76 Million
≈ $18.49 Million
0.236x +32.93%
2013-09-30 NT$2.11 Billion
≈ $66.57 Million
NT$374.74 Million
≈ $11.81 Million
0.177x +40.30%
2012-09-30 NT$1.96 Billion
≈ $61.74 Million
NT$247.71 Million
≈ $7.80 Million
0.126x -28.47%
2011-09-30 NT$2.05 Billion
≈ $64.73 Million
NT$363.06 Million
≈ $11.44 Million
0.177x +460.23%
2010-09-30 NT$2.27 Billion
≈ $71.41 Million
NT$71.50 Million
≈ $2.25 Million
0.032x -88.51%
2009-09-30 NT$1.70 Billion
≈ $53.59 Million
NT$466.80 Million
≈ $14.71 Million
0.274x --

About TAIDOC TECHNOLOGY CORP

TW:4736 Taiwan Medical Devices
Market Cap
$373.31 Million
NT$11.85 Billion TWD
Market Cap Rank
#13891 Global
#586 in Taiwan
Share Price
NT$126.00
Change (1 day)
+0.00%
52-Week Range
NT$116.50 - NT$143.50
All Time High
NT$162.52
About

TaiDoc Technology Corporation manufactures and markets medical devices in Taiwan and internationally. The company offers In vitro diagnostics products, including multiple parameter monitoring systems, point of care testing devices, and lancet and lancing devices; vet health care products comprise blood glucose and calcium meters, and blood ketone meters; and medical devices, such as nebulizers, t… Read more